Canadian online pharmacy platform SaveRxCanada has begun offering India-sourced Ozempic injections to U.S. patients, responding to growing demand for more affordable options.
The platform prices the diabetes drug from Novo Nordisk at around $280 per pen, significantly lower than typical U.S. retail prices of $900 to $1,100 per pen, depending on dose and location.
READ ALSO: Canada’s Annual Inflation Holds Steady at 2.2% in November Amid Rising Food Prices
SaveRxCanada offers pre-filled pens in 0.25 mg, 0.5 mg, and 1 mg doses, clearly disclosing the manufacturer and country of origin. All orders require a valid prescription and include free shipping.
A Novo Nordisk spokesperson said the company will investigate the matter. The U.S. Food and Drug Administration has not yet responded to inquiries. SaveRxCanada.to also did not immediately provide further details on sourcing.
READ ALSO: Canada’s Economy Beats Expectations with 2.6% Q3 Growth
The platform, which describes itself as an international prescription referral service, has been connecting patients with licensed pharmacies outside the U.S. for 24 years. Its services have gained attention as American patients face rising prescription drug costs.
Esther Ososanya is an investigative journalist with Pinnacle Daily, reporting across health, business, environment, metro, Fct and crime. Known for her bold, empathetic storytelling, she uncovers hidden truths, challenges broken systems, and gives voice to overlooked Nigerians. Her work drives national conversations and demands accountability one powerful story at a time.
